Hennion & Walsh Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
CPC
AIM
AAMU
AAIS
BCAM
Hennion & Walsh Asset Management's DGX Position: Q2 2026 in Review
Hennion & Walsh Asset Management reduced its Quest Diagnostics (DGX) stake by 6.4% in Q2 2026, selling an estimated $104K and leaving 7,712 shares worth $1.63M. The position accounts for 0.05% of the portfolio, ranked #437.
Hennion & Walsh Asset Management first reported a position in DGX in Q3 2021 and has held it in 16 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Hennion & Walsh Asset Management held 7,712 shares of Quest Diagnostics worth $1.63M as of Q2 2026.
- Hennion & Walsh Asset Management sold 528 Quest Diagnostics shares in Q2 2026, an estimated $104K.
- Quest Diagnostics made up 0.05% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #437 holding.
- Hennion & Walsh Asset Management first reported a position in Quest Diagnostics in Q3 2021 and has held it in 16 quarters since.
- 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.